About her
Fabiana Lacerca-Allen is the Senior Vice President of Compliance at Aimmune Therapeutics, a Nestle Health Science corporation, a biopharmaceutical company developing treatments for potentially life-threatening food allergies.
Practicing law and compliance for more than 30 years, Lacerca-Allen's passion as a compliance leader stems from values instilled in her at an early age and have helped to shape her career path as a global thought leader in law and compliance.
In addition to leading the compliance team at Aimmune, Lacerca-Allen serves as a member of the Board of Directors and an audit Committee member at Shield Therapeutics plc.
Lacerca has a track record of building and implementing successful compliance programs across Fortune 100 organizations, particularly within pharmaceutical, biotech and medical device industries.
Her expertise includes negotiating and implementing corporate integrity agreements, deferred prosecution agreements and consent decrees for U.S. corporations with extensive global operations.
Prior to her roles at Aimmune , Lacerca-Allen was the Senior Vice President and Chief Compliance Officer at Elan where she had global responsibilities in strategic initiatives and implementation of compliance programs.
Prior to this, she held roles as a Board Member at ArthroCare, Senior Vice President and Chief Compliance Officer at Mylan, Director of Compliance at Bristol Myers & Squibb and Senior Counsel at Microsoft.
Lacerca-Allen received her Bachelor of Law and Juris Doctor (J.D.) from the University of Buenos Aires and holds a Master of Laws (LL.M.) from the University of California, Los Angeles’ School of Law.
She frequently is invited to speak and participate on panels regarding compliance, leadership and managing risk.
She was recognized by Compliance Week in 2019 as a Top Mind, by The Guardian as a 2015 Women in Leadership, Inspiring Leader, and by Hispanic Executive in 2013 as a top Latino Executive among other recognitions.
Ms Lacerca-Allen is passionate about making a difference and giving back, she is also a Board Member of TCEL (the Center for Excellence in Life) a non-for profit organization dedicated to empowering youth through life skills development, mentoring and career counseling.
Experience information
- American Red Cross
- Member Board Of Directors Bay Area
- 2022 - to present
- Shield Therapeutics plc
- Board Member, Audit Committe
- 2021 - to present
- Senior Vice President Compliance Aimmune Therapeutics
- 2018 - 2023. San Francisco Bay Area
- President Ethiprax LLC
- 2014 - 2018
- Senior Vice President & Chief Compliance Officer
- 2010 - 2014
- Member of the Board ArthroCare Corporation
- 2013 - 2014
- Senior Vice President & Chief Compliance Officer Mylan Inc
- 2007 - 2010
- Director Compliance Bristol Myers & Squibb
- 2004 - 2007
- Senior Counsel Microsoft
- 2004 - 2004
- Director Legal Affairs Merck
- 1999 - 2004
- Director LA AT&T Capital
- 1997 - 1999